In vivo and in vitro production options for fungal secondary metabolites
- PMID: 18330989
- DOI: 10.1021/mp7001544
In vivo and in vitro production options for fungal secondary metabolites
Abstract
Microbial natural products, among them a vast diversity of fungal origin, represent a major source for new drug candidates. Focusing on fungal metabolites, our review covers recent advances in the field of biotransformation, heterologous expression, in vivo production approaches, genomics, and the metabolism of unexplored fungal groups as options to generate and identify new compounds or optimize known ones.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
